Author

Spencer Danner-Bocks

University of California, San FranciscoORCID 0009-0009-1435-7354Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew Pan· 1 shared Biswarathan RamaniiD· 1 shared Indigo V.L. RoseiD· 1 shared Jorge J. PalopiD· 1 shared Keran MaiD· 1 shared Lin Yadanar· 1 shared Martin KampmanniD· 1 shared Noam TeyssieriD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Andrew Pan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsbioRxivPreprintJun 13, 2023

CRISPR screening by AAV episome-sequencing (CrAAVe-seq) is a highly scalable cell type-specific in vivo screening platform

Biswarathan Ramani, Indigo V.L. Rose, Noam Teyssier…·Martin Kampmann

The paper introduces CrAAVe-seq, an AAV-based CRISPR screening platform for in vivo cell type-specific analysis, demonstrating its scalability and sensitivity in identifying neuron-essential genes.

11 citations

mouseCRISPR screen

𝕏 PostBluesky